1st International Conference on Chemo and BioInformatics, ICCBIKG  2021, (391-394)

AUTHOR(S) / AUTOR(I): Ana S. Kesić, Snežana R. Radisavljević, Biljana V. Petrović



Download Full Pdf   

DOI: 10.46793/ICCBI21.391K


Gold(III) complexes have found application in catalysis, materials science and medical inorganic chemistry. Considering that the right choice of inert ligands in the structure of Au(III) complexes is crucial for their properties and reactivity toward biomolecules, we have studied the substitution reactions between monofunctional Au(III) complex, [Au(Cl-Ph-tpy)Cl]Cl2 (Cl- Ph-tpy = 4′-(4-chlorophenyl)-2,2′:6′, 2″-terpyridine) and sulfur-donor biomolecules, glutathione (GSH) and L-methionine (L-Met), in 25 mM Hepes buffer (pH = 7.2) and 40 mM NaCl. The reactions were followed under the pseudo-first-order conditions as a function of ligand concentration and temperature, using the stopped-flow technique. Calculations were made by Microsoft Excel 2019 and Origin2019b 64Bit. Observed kinetics traces follow a single exponential function, suggesting that the process of the substitution undergoes as one reversible step. Also, L-Met was more reactive than GSH. This order is related to the positive inductive effect of the methyl group, which increases the nucleophilicity of the thioether. According to the values of the activation parameters, the reactions follow an associative model. These results demonstrate the strong connection between the reactivity of Au(III) complexes and the structural and electronic characteristics of the biologically important ligands.


gold(III), complex, kinetics, substitution, S-donor ligands


  • D. Mjos, C. Orvig., Metallodrugs in Medicinal Inorganic Chemistry, Chemical Reviews, 8 (2014) 4540−4563.
  • Gukathasan, S. Parkin, S. G. Awuah., Cyclometalated Gold(III) Complexes Bearing DACH Ligands, Inorganic Chemistry, 58 (2019) 9326−9340.
  • O. Omondia, S. O. Ojwacha, D. Jaganyi., Review of comparative studies of cytotoxic activities of Pt(II), Pd(II), Ru(II)/(III) and Au(III) complexes, their kinetics of ligand substitution reactions and DNA/BSA interactions, Inorganica Chimica Acta, 512 (2020) 119883- 119898.
  • B. Huang, F. Y. Wang, X. M. Tang, Z. F. Che, Y. C. Liu, Y. N. Liu, H. Liang., Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress Mediated Apoptosis and Pro-Death Autophagy in A549 CancerCells, Journal of Medicinal Chemistry, 61 8 (2018) 3478−3490.
  • Casado, M. Contel, M. Laguna, P. Romero, S. Sanz., Organometallic Gold(III) Compounds as Catalysts for the Addition of Water and Methanol to Terminal Alkynes, Journal of the American Chemical Society, 25 39 (2003)11925−11935.
  • S. Messina, J. M. Stauber, M. A. Waddington, A. L Rheingold, H. D. Maynard, A. M. Spokoyny., Organometallic Gold(III) Reagents for Cysteine Arylation, Journal of the American Chemical Society, 140 23 (2018) 7065−7069.
  • Casini, Messori., Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold CompoundsCurr, Current Topics in Medicinal Chemistry, 11 (2011) 2647–2660.
  • M. Nagy, L. Ronconi, C. Nardon, D. Fregona., Noble metal-dithiocarbamates precious allies in the fight against cancer, Mini-Reviews in Medicinal Chemistry, 12 (2012) 1216– 1229.
  • , On the medicinal chemistry of gold complexes as anticancer drugs, Coordination Chemistry Reviews, 253 (2009) 1670–1681.
  • T. Zou, C. T. Lum, C. N. Lok, J. J. Zhang, C. M. Che., Chemical biology of anticancer gold(iii) and gold(i) complexes, Chemical Society Reviews, 44 (2015) 8786–8801.
  • M. D. Nardon, G. Boscutti, D. Fregona., Beyond Platinums: Gold Complexes as Anticancer Agents, Anticancer Research, 34 (2014) 487–492.
  • M. L. Tobe, J. Burgess., Inorganic Reaction Mechanisms, Addison Wesley Longman Inc, Essex, (999) 70-112.
  • D. Đurović, Ž. D. Bugarčić, F. W. Heinemannb, R. van Eldik., Substitution versus redox reactions of gold(III) complexes with L-cysteine, L-methionine and glutathione, Dalton Transactions, 43 (2014) 3911-3921.